4
568 Alothman et al.
Asian J. Chem.
TABLE-5
POINT AND INTERVAL HYPOTHESIS TEST: EVALUATION OF APPLICABILITY OF THE PROPOSED METHOD
16
AND OBSERVATION OF RESULTS OF CURRENT METHOD WITH THE EXISTING METHOD
Recovery
%)
Reference method
Methods
RSD
θL
θU
t
F
(
Recovery
RSD
1.80
1.75
Initial rate
Fixed time
100.14
100.41
1.65
1.44
0.999
0.997
1.008
1.004
1.58
0.70
0.17
0.19
99.74
100.28
7
.
.
A.E. Medvedev,A. Clow, M. Sandler andV. Glover, Biochem. Pharmacol.,
2, 385 (1996).
A. Medvedev, O. Bussygyna, N. Pyatakova, V. Glover and I. Severina,
for determination of isatin are effective but are tedious, time-
consuming and require a large amount of sample and reagents
and sometimes vulnerable to contamination and losses of
analyte. Therefore, the current methods could be a better
alternate for the determination of isatin in pure form as well
as in mixtures (active drug + placebo) as these methods are
simple and sensitive and do not require any laborious cleanup
procedure prior to analysis and therefore, can be frequently
used in the laboratories of research, hospitals and pharma-
ceutical industries.
5
8
Biochem. Pharmacol., 63, 763 (2002).
9. S.K. Battacharya, A. Clow, A. Prareski, J. Halket,V. Glover and M.
Sandler, Neurosci. Lett., 132, 44 (1991).
0. H. Xu, D. Wang, W. Zhang, W. Zhu, K. Yamamoto and L. Jin, Anal.
Chim. Acta, 577, 207 (2006).
1
1
1
1
1
1. V.C. Diculescu, S. Kumbhat andA.M. Oliveira-Brett, Anal. Chim. Acta,
575, 190 (2006).
2. V. Manabe,Q. Gao, J. Yuan, T. Takahashi and A. Ueki, J. Chromatogr. B:
Biomed. Sci. Appl., 691, 197 (1997).
3. M. Unger, W. Jacobsen, U. Holzgrabe and L.Z. Benet, J. Chromatogr. B,
7
67, 245 (2002).
4. J.M. Halket, P.J. Watkins, A. Przyborowska, B.L. Goodwin, A. Clow,
ACKNOWLEDGEMENTS
V. Glover and M. Sandler, J. Chromatogr. B: Biomed. Appl., 562, 279
(
The authors (Z.A.O, M.R.S, S.M.W) extended their
appreciation to the Deanship of Scientific Research at King
Saud University for funding the work through the research
group project No. RGP-VPP-043.
1991).
5. K.-I. Mawatari, M. Segawa, R. Masatsuka, Y. Hanawa, F. Iinuma and
M. Watanabe, Analyst, 126, 33 (2001).
1
1
6. Z. Xiang-Hui, X. Wei and L. Jun, J. Shanxi Normal Univ., [DOI]:
CNKI:SUN:SFDX.0.2008-02-018.http://en.cnki.com.cn/Article_en/
CJFDTOTAL-SFDX200802018.htm.
REFERENCES
1
1
1
2
2
7. Vogel's Textbook of Quantitative Chemical Analysis, Pearson Education,
Singapore, edn. 6, p. 420 (2002).
1
2
.
.
P. Zou and H.L. Koh, Rapid Commun. Mass Spectrom., 21, 1239 (2007).
Silva J.F.M. Da, S.J. Garden and A.C. Pinto, J. Braz. Chem. Soc., 12,
8. S. Riahi, F. Hadiloo, S.M.R. Milani, N. Davarkhah, M.R. Ganjali, P.
Norouzi and P. Seyfi, Drug Testing Anal., 3, 319 (2011).
9. N. Rahman, M.R. Siddiqui and S.N.H. Azmi, J. Chin. Chem. Soc., 53,
273 (2001).
3
4
5
6
.
.
.
.
N. Hamaue, N.Yamazaki, M. Minami, M. Endo, M. Hirahuji,Y. Monma
and H. Togashi, Gen. Pharmacol., 30, 387 (1998).
B. Bhrigu, D. Pathak, N. Siddiqui, M.S.Alam andW.Ahsan, Int. J. Pharm.
Sci. Drug Res., 2, 229 (2010).
735 (2006).
0. C. Hartmann, J. Smeyers-Verbeke, W. Penninck, Y.V. Hayden, P.
Venkeerberghen and D.L. Masart, Anal. Chem., 67, 4491 (1995).
1. Canada Health Protection Branch, Drug Directorate Guidelines, Ac-
ceptable Methods, Ministry of National Health and Welfare Draft
V. Glover, S.K. Bhattacharya, A. Chakrabarti and M. Sandler, Stress
Med., 14, 225 (1998).
V. Glover, M. Reveley and M. Sandler, Biochem. Pharmacol., 29, 467
(1992).
2. A.M. Ismail and A.A. Zaghloul, Int. J. Chem. Kinet., 30, 463 (1998).
2
(
1980).